http://www.mmm-online.com/generic/topic/206/ Articles tagged with Generic from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi's iBGStar may have a competitor. http://www.mmm-online.com/business-briefs-pfizer-bms-cms-sanofi/article/293671/ Thu, 16 May 2013 16:50:50 GMT Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi's iBGStar may have a competitor. MMM Bayer's prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations http://www.mmm-online.com/business-briefs-bayer-fda-ranbaxy/article/293533/ Wed, 15 May 2013 19:13:18 GMT Bayer's prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations MMM Jolie takes on cancer awareness role, researchers identify another adherence gap, Sanofi gets slapped for scare tactics, Teva may compete for Adcock, AbbVie R&D chief leaves http://www.mmm-online.com/business-briefs-angelina-jolie-adherence-sanofi-teva-abbvie/article/293341/ Tue, 14 May 2013 18:54:50 GMT Jolie takes on cancer awareness role, researchers identify another adherence gap, Sanofi gets slapped for scare tactics, Teva may compete for Adcock, AbbVie R&D chief leaves MMM Two studies released show that the story behind lower consumer healthspend isn't about generics improving health. http://www.mmm-online.com/studies-show-cheaper-drugs-dont-add-up-to-greater-use/article/292626/ Thu, 09 May 2013 16:09:46 GMT Two studies released show that the story behind lower consumer healthspend isn't about generics improving health. MMM GSK and Astellas kick off the race for a new anemia treatment; Orexigen's CEO joins PhRMA; BMS and Merck team up in a hep.-C clinical trial; Novartis lands glaucoma approval; Ireland starts naming preferred drugs; Novo has new New Jersey digs; Vertex releases promising data for new cystic fibrosis treatment. http://www.mmm-online.com/business-briefs-gsk-astellas-vertex-and-orexigen/article/289879/ Mon, 22 Apr 2013 16:19:10 GMT GSK and Astellas kick off the race for a new anemia treatment; Orexigen's CEO joins PhRMA; BMS and Merck team up in a hep.-C clinical trial; Novartis lands glaucoma approval; Ireland starts naming preferred drugs; Novo has new New Jersey digs; Vertex releases promising data for new cystic fibrosis treatment. MMM AstraZeneca cuts a deal with OCB to test unnamed cancer drug; an Enbrel biosimilar launches in India; BMS and Santaris seal an mRNA tech deal; Merck expands its China presence; Alzheimer's advocacy group parents a spin-off. http://www.mmm-online.com/business-briefs-astrazeneca-amgen-bms-and-merck/article/289378/ Thu, 18 Apr 2013 15:21:51 GMT AstraZeneca cuts a deal with OCB to test unnamed cancer drug; an Enbrel biosimilar launches in India; BMS and Santaris seal an mRNA tech deal; Merck expands its China presence; Alzheimer's advocacy group parents a spin-off. MMM Boston Scientific's new CEO takes office, Watson creates a generics management team http://www.mmm-online.com/people-news-boston-scientific-watson/article/266580/ Thu, 01 Nov 2012 18:22:21 GMT Boston Scientific's new CEO takes office, Watson creates a generics management team MMM The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding. http://www.mmm-online.com/oped-meningitis-crisis-and-the-threat-to-pharma/article/263094/ Wed, 10 Oct 2012 19:06:58 GMT The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding. MMM The agency did a head-to-head comparison of Impax/Teva's generic Wellbutrin XL 300 against the brand and found they are not the same. http://www.mmm-online.com/fda-says-a-wellbutrin-generic-fails-bioequivalence-test/article/262280/ Thu, 04 Oct 2012 17:53:38 GMT The agency did a head-to-head comparison of Impax/Teva's generic Wellbutrin XL 300 against the brand and found they are not the same. MMM The FDA gave green lights on two drugs days before the long weekend, and Novartis said Phase III COPD trials are shaping up to lead to regulatory filings. http://www.mmm-online.com/fda-nods-for-teva-jj-signal-pipeline-progress/article/256785/ Thu, 30 Aug 2012 16:31:00 GMT The FDA gave green lights on two drugs days before the long weekend, and Novartis said Phase III COPD trials are shaping up to lead to regulatory filings. MMM